SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-032748
Filing Date
2021-08-12
Accepted
2021-08-12 16:15:15
Documents
1
Period of Report
2021-01-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 12826
  Complete submission text file 0000899243-21-032748.txt   17469
Mailing Address C/O NEW LEAF VENTURE PARTNERS 7 TIMES SQUARE, SUITE 3502 NEW YORK NY 10036
Business Address C/O NEW LEAF VENTURE PARTNERS 7 TIMES SQUARE, SUITE 3502 NEW YORK NY 10036 646-871-6400
New Leaf Ventures III, L.P. (Reporting) CIK: 0001625653 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38800 | Film No.: 211167745

Mailing Address C/O NEW LEAF VENTURE PARTNERS 7 TIMES SQUARE, SUITE 3502 NEW YORK NY 10036
Business Address C/O NEW LEAF VENTURE PARTNERS 7 TIMES SQUARE, SUITE 3502 NEW YORK NY 10036 646-871-6400
New Leaf Venture Associates III, L.P. (Reporting) CIK: 0001625656 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38800 | Film No.: 211167744

Mailing Address C/O NEW LEAF VENTURE PARTNERS 7 TIMES SQUARE, SUITE 3502 NEW YORK NY 10036
Business Address C/O NEW LEAF VENTURE PARTNERS 7 TIMES SQUARE, SUITE 3502 NEW YORK NY 10036 646-871-6400
New Leaf Venture Management III, L.L.C. (Reporting) CIK: 0001625657 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38800 | Film No.: 211167743

Mailing Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-443-7400
Harpoon Therapeutics, Inc. (Issuer) CIK: 0001708493 (see all company filings)

IRS No.: 473458693 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 420 LEXINGTON AVENUE, SUITE 408 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE, SUITE 408 NEW YORK NY 10170 (646) 871-6400
New Leaf Biopharma Opportunities II, L.P. (Reporting) CIK: 0001735293 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38800 | Film No.: 211167742

Mailing Address 420 LEXINGTON AVENUE, SUITE 408 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE, SUITE 408 NEW YORK NY 10170 (646) 871-6400
New Leaf BPO Management II, L.L.C (Reporting) CIK: 0001740755 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38800 | Film No.: 211167740

Mailing Address 420 LEXINGTON AVENUE, SUITE 408 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE, SUITE 408 NEW YORK NY 10170 (646) 871-6400
New Leaf BPO Associates II, L.P. (Reporting) CIK: 0001740783 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38800 | Film No.: 211167741